AFP, which is a valuable in situ and serum marker for the hepatocyte lineage, and also the most important prognostic marker in HCC, showed no significant difference in immunohistochemistry (Figure 7C) or serum levels (rs (E-cadherin) = 0.06, p = 0.42, n = 188; rs (N-cadherin) = −0.04, p = 0.641, n = 188). The gene discussed is CDH1; the disease is hepatocellular carcinoma.